FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/11/2024
Back to search
Official data from USPTO
ONCOLINES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/11/2024
Trademark type
Word
Nice classes
42
Filing date
10/07/2022
Registration date
02/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
02/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
26
Owner location
NL
Examiner
GANESH, HARINI
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Oncolines B.V.
Representatives
E. Anthony Figg Rothwell, Figg, Ernst & Manbeck, PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research for medical purposes in the area of cancerous diseases; providing laboratory research in the field of gene expressioncancer biology; medical research servicesperforming proliferation assays in vitro with cell ines; scientific research services relating to testing of substancesdrugs and pharmaceutical preparations in vitro with cell lines for scientific research purposes; scientific research servicesperforming protein kinase assays; scientific research services relating to testing of substancesdrugs and pharmaceutical preparations in protein kinase assays for scientific research purposes; scientific research servicesperforming enzyme assays; consultancy relating to research and development in the field of medicines and pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/15/2024
FIMP
FINAL DISPOSITION PROCESSED
05/15/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/13/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2023
PUBO
PUBLISHED FOR OPPOSITION
11/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/24/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2023
RFNT
REFUSAL PROCESSED BY IB
09/25/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2023
RFRR
REFUSAL PROCESSED BY MPU
09/05/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/16/2023
CNRT
NON-FINAL ACTION WRITTEN
08/15/2023
DOCK
ASSIGNED TO EXAMINER
07/24/2023
MAFR
APPLICATION FILING RECEIPT MAILED
11/24/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/20/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/17/2022
Continuous trademark protection
Get notified about every new filing that threatens ONCOLINES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.